IRINOTECAN FOR CHILDREN WITH RELAPSED SOLID TUMORS-Reference-Cited by-同舟云学术

IRINOTECAN FOR CHILDREN WITH RELAPSED SOLID TUMORS

Published:2006-01 Issue:2 Volume:23 Page:103-110
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Shitara Toshiji,Shimada Akira,Hanada Ryoji,Matsunaga Tadashi,Kawa Keisei,Mugishima Hideo,Sugimoto Tohru,Mimaya Jun-ichi,Manabe Atsushi,Tsurusawa Masahito,Tsuchida Yoshiaki

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

http://www.tandfonline.com/doi/pdf/10.1080/08880010500457152

Reference32 articles.

1. Phase I study of topotecan for pediatric patients with malignant solid tumors.

2. Topotecan and Irinotecan in the Treatment of Pediatric Solid Tumors

3. Topoisomerase I inhibitors and other new cytotoxic drugs

4. An early phase II study of CPT-11: a new derivative of camptothecin, for the treatment of leukemia and lymphoma.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of vincristine, irinotecan and anlotinib in Epithelioid Sarcoma;BMC Cancer;2024-02-03

2. A potential alternative systemic treatment option for epithelioid sarcoma;2022-12-22

3. Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literatureA report from the SIOP Renal Tumor Study Group;PEDIATR BLOOD CANCER;2018

4. Phase I study of bortezomib in combination with irinotecan in patients with relapsed/refractory high-risk neuroblastoma;Pediatric Blood & Cancer;2017-04-24

5. Fifteen years of irinotecan therapy for pediatric sarcoma: where to next?;Clinical Sarcoma Research;2015-08-28